Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CIMPRESS plc
Report date November 13, 2018 · Filed November 14, 2018
Section 16 reporting ended · disclosed 2018-11-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 12,918 |
Reported balance
After 2018-11-13 transaction · row 1
1 source rowRow 1 · 2018-11-13 · Grant · Acquired 1,500 · Balance 12,918 F1: Pursuant to the share award agreement between Cimpress and the reporting person, these ordinary shares may not be sold or otherwise disposed of until November 13, 2021. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy LLC | 1,800 |
Reported balance
Holding disclosure · report date 2018-11-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,800 F2: Held by Thomas Family LLC of which the reporting person is the manager. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the share award agreement between Cimpress and the reporting person, these ordinary shares may not be sold or otherwise disposed of until November 13, 2021.
F2: Held by Thomas Family LLC of which the reporting person is the manager.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2018 Filed Nov 14, 2018 10:27 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantOrdinary Shares | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001262976-18-000095 · wf-form4_154220921052584.xml · nonDerivative · entry 1 Thomas Mark · CIK 0001474461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,918 F1 · kind: Pursuant to the share award agreement between Cimpress and the reporting person, these ordinary shares may not be sold or otherwise disposed of until November 13, 2021. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 11:44 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 1,291 | $0.00 Strike: $87.12 | $0.00 |
DisclosureSEC source: 0001209191-17-061378 · doc4.xml · derivative · entry 1 Thomas Mark · CIK 0001474461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,291 Underlying: Ordinary Shares · 1,291 shares Expires 2027-11-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average daily price per share of Cimpress' ordinary shares ("3YMA") on the date of grant, which is the baseline against which the compound annual growth rate ("CAGR") of the 3YMA will be measured. F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each November 13 of 2018 through 2021 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 12:51 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionShare Option (right to buy) · Derivative | 2,443 | $0.00 Strike: $40.99 | $0.00 |
DisclosureSEC source: 0001209191-17-059060 · doc4.xml · derivative · entry 5 Thomas Mark · CIK 0001474461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,443 shares Expires 2020-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on January 30, 2017. F2 · derivative.exercise_date: The option vested at a rate of 8.33% of the original number of ordinary shares each successive three-month period following the grant date until the third anniversary of the grant date. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 12:51 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionShare Option (right to buy) · Derivative | 5,758 | $0.00 Strike: $54.46 | $0.00 |
DisclosureSEC source: 0001209191-17-059060 · doc4.xml · derivative · entry 4 Thomas Mark · CIK 0001474461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,758 shares Expires 2019-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on January 30, 2017. F2 · derivative.exercise_date: The option vested at a rate of 8.33% of the original number of ordinary shares each successive three-month period following the grant date until the third anniversary of the grant date. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 12:51 UTC | CIMPRESS plc CMPR · Entity 4457 | SaleOrdinary Shares | 15,025 | $120.00 | $1,803,000.00 |
DisclosureSEC source: 0001209191-17-059060 · doc4.xml · nonDerivative · entry 3 Thomas Mark · CIK 0001474461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,795 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on January 30, 2017. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 12:51 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 2,443 | $40.99 | $100,138.57 |
DisclosureSEC source: 0001209191-17-059060 · doc4.xml · nonDerivative · entry 2 Thomas Mark · CIK 0001474461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on January 30, 2017. Read SEC document |
| November 02, 2017 Filed Nov 3, 2017 12:51 UTC | CIMPRESS plc CMPR · Entity 4457 | Exercise / conversionOrdinary Shares | 5,758 | $54.46 | $313,580.68 |
DisclosureSEC source: 0001209191-17-059060 · doc4.xml · nonDerivative · entry 1 Thomas Mark · CIK 0001474461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on January 30, 2017. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:32 UTC | CIMPRESS plc CMPR · Entity 4457 | GrantPerformance Share Units · Derivative | 1,541 | $0.00 Strike: $72.97 | $0.00 |
DisclosureSEC source: 0001209191-16-150875 · doc4.xml · derivative · entry 1 Thomas Mark · CIK 0001474461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,541 Underlying: Ordinary Shares · 1,541 shares Expires 2026-11-15 F1 · derivative.exercise_price: This dollar amount is the three-year moving average daily price per share of Cimpress' ordinary shares ("3YMA") on the date of grant, which is the baseline against which the compound annual growth rate ("CAGR") of the 3YMA will be measured. F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each November 14 of 2017 through 2020 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.